EU probes Aspen price-hiking allegations The Aspen share price held up reasonably well on Tuesday after confirmation that the European Commission had launched a Europe-wide investigation into alleged price hiking of critical cancer drugs. Source: EU probes Aspen price-hiking allegations By Leigh Peiser|2018-03-29T13:01:33+00:00May 18th, 2017|Company Updates, Competition Commission, Health & Beauty|0 Comments Share This Story, Choose Your Platform! FacebookXRedditLinkedInTumblrPinterestVkEmail About the Author: Leigh Peiser Leave A Comment Cancel replyYou must be logged in to post a comment.
Leave A Comment
You must be logged in to post a comment.